|4Feb 4, 12:27 PM ET

Behr Allen C 4

4 · NUCOR CORP · Filed Feb 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Nucor (NUE) EVP Allen C. Behr Exercises Options, Sells 15,068 Shares

What Happened

  • Allen C. Behr, Executive Vice President of Nucor (NUE), exercised employee stock options and immediately sold the shares. He exercised 7,500 options on Feb 2, 2026 (exercise price $42.46; cost $318,450) and 7,568 options on Feb 3, 2026 (exercise price $42.46; cost $321,337). He sold the resulting 7,500 shares on Feb 2 at an average price of $181.07 (proceeds ~$1.358M) and 7,568 shares on Feb 3 at $188.50 (proceeds ~$1.427M). Total gross proceeds from the sales were about $2.785M; total exercise cost was $639,787, yielding approximate net proceeds of $2.145M.

Key Details

  • Transaction dates: Feb 2, 2026 and Feb 3, 2026.
  • Exercise price(s): $42.46 per share (employee stock options).
  • Sales prices: weighted averages — $181.07 (Feb 2 sale) and $188.50 (Feb 3 sale). Footnote: one sale’s prices ranged from $188.400 to $188.775; full breakdown available on request (Footnote F1).
  • Instruments: Employee stock options (Footnote F2). The filing shows the option awards were exercised (acquisition) and the derivative instruments were cancelled/converted (reported as disposed at $0).
  • Shares owned after transaction: not specified in the reported Form 4.
  • Filing timeliness: Reported on Feb 4, 2026 for transactions on Feb 2–3; this appears to be a timely Form 4 filing (not indicated as late).

Context

  • This was an option exercise followed by immediate open-market sales (a cashless or sell-to-cover pattern), a common way for executives to realize value from vested options. Such sales are routine monetization and do not, by themselves, indicate a change in an insider’s view of the company.
  • The filing is factual and does not state any trading plan (e.g., 10b5-1) in the provided data.

Insider Transaction Report

Form 4
Period: 2026-02-02
Behr Allen C
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-02$42.46/sh+7,500$318,45075,211.16 total
  • Sale

    Common Stock

    2026-02-02$181.07/sh7,500$1,358,02667,711.16 total
  • Exercise/Conversion

    Common Stock

    2026-02-03$42.46/sh+7,568$321,33775,279.16 total
  • Sale

    Common Stock

    [F1]
    2026-02-03$188.50/sh7,568$1,426,55567,711.16 total
  • Exercise/Conversion

    Stock Option

    [F2]
    2026-02-027,5007,568 total
    Exercise: $42.46From: 2023-06-01Exp: 2030-05-31Common Stock (7,500 underlying)
  • Exercise/Conversion

    Stock Option

    [F2]
    2026-02-037,5680 total
    Exercise: $42.46From: 2023-06-01Exp: 2030-05-31Common Stock (7,568 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.400 to $188.775, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F2]Employee Stock Option (right to buy)
Signature
/s/ Caitlin A. Kelly, attorney-in-fact for Mr. Behr|2026-02-04

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT